Seagen (SGEN) Stock Up on Rumors of Acquisition by Merck

04:19pm, Monday, 20'th Jun 2022 Zacks Investment Research
Shares of Seagen (SGEN) rise after rumors of a buyout by Merck hit the market. However, a deal is not imminent at the moment.
The Dow Jones Industrial Average won't be trading on Monday when the new Juneteenth federal holiday is observed.

Best Health Care Stocks To Buy Now? 3 To Watch

09:31am, Monday, 20'th Jun 2022
Check out these health care stocks this holiday-shortened week.

The Zacks Analyst Blog Highlights Lilly, Merck, Roche, Pfizer and Moderna

09:24am, Monday, 20'th Jun 2022 Zacks Investment Research
Lilly, Merck, Roche, Pfizer and Moderna have been included in this Analyst Blog.

Why Seagen Surged Today

07:26pm, Friday, 17'th Jun 2022 The Motley Fool
Merck is thinking about whether it's an appealing acquisition target.
Biopharma giant Merck is considering an acquisition of Seagen, the Seattle area's biggest biotech company, according to a report in the Wall Street Journal Friday.
Shares of Seagen Inc. ( SGEN , Financial) climbed more than 16% to about $170 on Friday as investors piled into the stock on rumors the company was being eyed by Merck & Co. Inc. ( MRK , Financial). A
Today, various reports have highlighted a potential deal for Merck to buy out Seagen, taking SGEN stock on a nice ride this afternoon. The post SGEN Stock Alert: Is Merck About to Buy Seagen?
Pfizer's Paxlovid and Merck's Lagevrio can prevent cases of COVID from turning truly serious.

These 2 Dividend ETFs Are a Retiree's Best Friend

01:17pm, Friday, 17'th Jun 2022 The Motley Fool
These ETFs provide a hassle-free way to boost your retirement income.

Pharma Stock Roundup: FDA Panel Nod for PFE, MRNA Young Kids' COVID Jabs & More

12:37pm, Friday, 17'th Jun 2022 Zacks Investment Research
FDA panel recommends the use of PFE, MRNA COVID vaccine in kids under five. LLY's Alzheimer's candidate fails to show clinical benefit in study. FDA approves expanded use of LLY's Olumiant.

Merck Shows Takeover Interest In Seagen: WSJ

11:27am, Friday, 17'th Jun 2022
Merck & Co Inc (NYSE: MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ: SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens,
Drugmaker Merck & Co is considering buying cancer-focused biotech company Seagen Inc, the Wall Street Journal reported on Friday, citing people familiar with the matter.
Shares of Seagen Inc. SGEN, +12.02% shot up 14.7% toward a seven-month high in morning trading Friday, after The Wall Street Journal reported that Merck & Co. Inc. MRK, -0.02% is looking into buying t
If you only have $250 to spend, here are the best Dow stocks to buy based on the current macroeconomic dynamics. The post The 7 Smartest Dow Stocks to Buy if You Have $250 Right Now appeared first on
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE